Chemical Structure of molecule BMS-986202 potent

oral JH2-binding Tyk2 inhibitor

Ph. I in psoriasis complete

backup candidate to BMS-986165 for psoriasis

J. Med. Chem., Dec. 28, 2020

Bristol-Myers Squibb, Princeton, NJ

Bristol Myers Squibb (BMS) oral JH2-domain binding Tyk2 kinase inhibitor


 this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.